Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 23559898)

1.

Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist.

Lee YR, Lee YH, Kim KH, Im SA, Lee CK.

Immune Netw. 2013 Feb;13(1):30-3. doi: 10.4110/in.2013.13.1.30. Epub 2013 Feb 28.

2.

Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.

Lee YR, Lee YH, Im SA, Yang IH, Ahn GW, Kim K, Lee CK.

Arch Pharm Res. 2010 Nov;33(11):1859-66. doi: 10.1007/s12272-010-1119-z. Epub 2010 Nov 30.

PMID:
21116790
3.

Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.

Diwan M, Elamanchili P, Lane H, Gainer A, Samuel J.

J Drug Target. 2003;11(8-10):495-507.

PMID:
15203918
4.

Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.

Rattanakiat S, Nishikawa M, Takakura Y.

Eur J Pharm Sci. 2012 Sep 29;47(2):352-8. doi: 10.1016/j.ejps.2012.06.015. Epub 2012 Jul 6.

PMID:
22771546
5.
6.

Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant.

Mueller M, Schlosser E, Gander B, Groettrup M.

Int J Cancer. 2011 Jul 15;129(2):407-16. doi: 10.1002/ijc.25914. Epub 2011 Mar 28.

PMID:
21207410
7.
8.

Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response.

Fischer S, Schlosser E, Mueller M, Csaba N, Merkle HP, Groettrup M, Gander B.

J Drug Target. 2009 Sep;17(8):652-61. doi: 10.1080/10611860903119656.

PMID:
19622019
9.

Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery.

Diwan M, Elamanchili P, Cao M, Samuel J.

Curr Drug Deliv. 2004 Oct;1(4):405-12.

PMID:
16305402
10.

Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL.

Klimuk SK, Najar HM, Semple SC, Aslanian S, Dutz JP.

J Invest Dermatol. 2004 Apr;122(4):1042-9.

11.

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

de Jong S, Chikh G, Sekirov L, Raney S, Semple S, Klimuk S, Yuan N, Hope M, Cullis P, Tam Y.

Cancer Immunol Immunother. 2007 Aug;56(8):1251-64. Epub 2007 Jan 23.

PMID:
17242927
13.

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.

Maurer T, Heit A, Hochrein H, Ampenberger F, O'Keeffe M, Bauer S, Lipford GB, Vabulas RM, Wagner H.

Eur J Immunol. 2002 Aug;32(8):2356-64.

PMID:
12209649
14.
15.

Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen.

Lee YR, Lee YH, Im SA, Kim K, Lee CK.

Immune Netw. 2011 Jun;11(3):163-8. doi: 10.4110/in.2011.11.3.163. Epub 2011 Jun 30.

16.
17.

Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.

San Román B, Gómez S, Irache JM, Espuelas S.

J Pharm Pharm Sci. 2014 Oct-Dec;17(4):541-53.

18.

Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells.

Heo MB, Lim YT.

Biomaterials. 2014 Jan;35(1):590-600. doi: 10.1016/j.biomaterials.2013.10.009. Epub 2013 Oct 11.

PMID:
24125775
19.

Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.

Lee YH, Lee YR, Kim KH, Im SA, Song S, Lee MK, Kim Y, Hong JT, Kim K, Lee CK.

Int Immunopharmacol. 2011 Aug;11(8):985-91. doi: 10.1016/j.intimp.2011.02.013. Epub 2011 Feb 24.

PMID:
21354357
20.

Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.

San Román B, Irache JM, Gómez S, Tsapis N, Gamazo C, Espuelas MS.

Eur J Pharm Biopharm. 2008 Sep;70(1):98-108. doi: 10.1016/j.ejpb.2008.03.015. Epub 2008 Mar 31.

PMID:
18501572
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk